Presentations and press

Video presentations and interviews

• "Sareum Holdings raises over a £1mln to advance preclinical work on its TYK2/JAK1 drugs" Proactive Investors, June 2020
• "Next Generation TYK2/JAK1 Immunotherapeutics for Autoimmune Diseases and Cancer (and Covid-19)" BioTrinity, April 2020
• "Sareum Holdings new licensing deal 'could generate significant near-term milestone revenue'" Proactive Investors, March 2020
• "Sareum's Tim Mitchell looks ahead to critical Phase II data from flagship Chk1 inhibitor" Proactive Investors, March 2019
• "Sareum Holdings plc heartened by Sierra Oncology Progress" Proactive Investors, March 2018

Audio presentations

• Cancer drug payment nudges Sareum Holdings into maiden profit - Proactive Investors, February 2017
• Licensing deal "a validation of Sareum's business model" - Proactive Investors, November 2016
• How did Sareum Holdings perform in its final results? - Share Radio, November 2016
• Sareum 'very excited' by TYK2 inhibitor results says chief scientific officer - Proactive Investors, October 2016
• CEO Dr Tim Mitchell talks about Sareum - Share Radio, October 2016
• Chk1 Licence Deal - ProNAi Webcast, September 2016
• Chk1 Licence Deal - Proactive Investors, September 2016

Slide presentations

• BIO Digital, June 2020
• BioTrinity, April 2020
• Half-yearly Results Presentation March 2020
• Final Results Presentation 2018/19

In the news

• Cambridge Independent "Sareum raises £1m to advance preclinical studies and targets Covid-19 cytokine storm" Link to online article 10 June 2020
• Business Weekly "Sareum buoyed by China pharma licensing deal" Link to online article 26 March 2020
• Cambridge News "Sareum turns a profit after spectacular six months" Link to online article 20 February 2017
• Business Weekly "Sareum posts maiden profit" Link to online article 20 February 2017
• Cambridge News "Why Sareum is in the money again" Link to online article 11 January 2017
• Cambridge Business "Little Big Firm" Link to online article p85-87, December 2016  Download Article PDF
• Cambridge News "CEO 'delighted' with progress at cancer drug firm Sareum" Link to online article 2 November 2016
• Business Weekly "Japan and Singapore patents for Sareum Technology" Link to online article 20 October 2016
• Cambridge News "Celebrate Cambridge: high time for life sciences" Link to online article 28 September 2016
• City AM "Cambridge biotech firm sees shares jump over 100 per cent on US pharma deal"  Link to online article 27 September 2016
• Cambridge News "Share price leaps 150% for Cambridge cancer company"  Link to online article 27 September 2016
• Genetic Engineering & Biotechnology News "ProNAi Licenses Checkpoint Kinase 1 Inhibitor..." Link to online article 27 September 2016
• Business Weekly "US deal hands Sareum share of potential $328M windfall" Link to online article 27 September 2016
• Business Weekly "China and Hong Kong patent boost for Sareum" Link to online article 8 August 2016
• Cambridge News "Movers and shakers: new chairman for Sareum..." Link to online article 24 May 2016
• Cambridge News "Cambridge cancer drug company sees share price zoom" Link to online article 5 April 2016
• Cambridge News "Sareum helps develop 'chemotherapy-booster' for patients with lung and pancreatic cancer" Link to online article 27 July 2015
• Cambridge News "Sareum lands £140K to develop molecule that could treat leukaemia". Link to online article 23 June 2015
• Cambridge News, "Sareum Signs China Deal". Link to online article 3 December 2013
• Cambridge News, "High Hopes for New Sareum Cancer Drug". Link to online article 16 August 2011
• Cambridge News, "Star Status for Sareum". Link to online article 6 July 2011
• Interactive Investor, "AIM Winners and Losers (01/01 - 30/06/11)". Link to online article 5 July 2011
• Cambridge News, "Tenfold Growth in Two Months". Download PDF or Link to online article 24 May 2011